The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new anticounterfeiting strategy with the aim of curbing the occurrence of falsified medicines in the county’s supply chain. The strategy will focus on prevention, incident management, and investigation of all reports of falsified medicines in the UK.
According to the MHRA:
“The new strategy, the Falsified Medical Products Strategy 2012 – 2015, details measures that the MHRA will take to tackle counterfeit medicines and medical devices. It brings together its stakeholders and international partners to combine efforts in raising public awareness and carrying out enforcement policy.”
For further details see MHRA